Supernus Pharmaceuticals, Inc. (SUPN)
40.70
-1.37
(-3.26%)
USD |
NASDAQ |
Oct 23, 16:00
40.68
-0.02
(-0.06%)
After-Hours: 20:00
Supernus Pharmaceuticals Price : 40.70 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 41.68 | 41.95 | 39.96 | 40.70 | 1.159M |
| Oct 22, 2026 | 41.52 | 42.09 | 40.73 | 42.07 | 937420.0 |
| Oct 21, 2026 | 41.23 | 42.00 | 40.86 | 41.21 | 1.006M |
| Oct 20, 2026 | 39.95 | 41.74 | 39.77 | 41.23 | 1.240M |
| Oct 19, 2026 | 37.77 | 40.52 | 37.76 | 39.84 | 1.509M |
| Oct 16, 2026 | 39.49 | 39.50 | 37.54 | 37.88 | 1.442M |
| Oct 15, 2026 | 40.21 | 41.31 | 39.36 | 39.57 | 1.013M |
| Oct 14, 2026 | 41.93 | 43.26 | 39.97 | 40.18 | 906716.0 |
| Oct 13, 2026 | 42.94 | 43.29 | 41.71 | 42.01 | 1.197M |
| Oct 12, 2026 | 42.67 | 43.20 | 41.90 | 42.81 | 914563.0 |
| Oct 09, 2026 | 42.18 | 43.14 | 42.15 | 42.67 | 643833.0 |
| Oct 08, 2026 | 42.41 | 43.40 | 41.14 | 42.14 | 684161.0 |
| Oct 07, 2026 | 42.24 | 43.38 | 42.24 | 43.05 | 571037.0 |
| Oct 06, 2026 | 42.86 | 43.12 | 41.40 | 42.83 | 748264.0 |
| Oct 05, 2026 | 42.38 | 43.20 | 42.38 | 42.76 | 1.288M |
| Oct 02, 2026 | 42.47 | 43.15 | 41.88 | 42.38 | 739805.0 |
| Oct 01, 2026 | 43.21 | 43.68 | 42.15 | 42.18 | 424631.0 |
| Sep 30, 2026 | 44.03 | 44.18 | 43.03 | 43.04 | 685590.0 |
| Sep 29, 2026 | 44.39 | 44.93 | 43.20 | 43.97 | 551595.0 |
| Sep 28, 2026 | 42.59 | 44.61 | 42.38 | 44.60 | 731229.0 |
| Sep 25, 2026 | 43.21 | 43.69 | 42.65 | 42.66 | 607569.0 |
| Sep 24, 2026 | 43.22 | 44.00 | 42.76 | 43.29 | 589012.0 |
| Sep 23, 2026 | 43.66 | 44.46 | 43.14 | 43.39 | 544531.0 |
| Sep 22, 2026 | 43.04 | 44.25 | 42.82 | 43.75 | 667588.0 |
| Sep 21, 2026 | 42.00 | 42.97 | 41.68 | 42.78 | 635722.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Indivior Pharmaceuticals, Inc. | 34.47 |
| Prestige Consumer Healthcare, Inc. | 47.80 |
| Amphastar Pharmaceuticals, Inc. | 25.14 |
| Bristol Myers Squibb Co. | 61.48 |
| Liquidia Corp. | 42.65 |
Price Related Metrics
| PS Ratio | 2.813 |
| Price to Book Value | 2.296 |
| Price to Free Cash Flow | 124.36 |
| Earnings Yield | -4.70% |
| Market Cap | 2.367B |